Platform Diagnostics holds the IPR in capillary agglutination technology. BBI and Carclo are continuing with the development of POC products based on CAT technology.

Principles of the agglutination have been adapated for use in conventional membrane based devices (Membrane Agglutination Technology). This family of patents is available for licensing to third parties.